Concepedia

Author

Patrick Chun

The University of Texas MD Anderson Cancer Center

Also Known As

P Y Chun, Patrick Chun, Patrick Y Chun, Patrick Y. Chun, Patrick Youngwhan Chun

42

Publications

594

Citations

11

H-Index

33

Concepts

All Affiliations

The University of Texas MD Anderson Cancer CenterUniversity of MichiganMerck & Co., Inc., Rahway, NJ, USA (United States)University of California, Los AngelesMoffitt Cancer Center
PC

About

Patrick Chun is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, radiation oncology, and oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

6

6

249

2

Immunology

4

4

100

3

Cell Biology

2

2

149

4

Health Sciences

1

1

40

5

Pathology

1

1

23

Patrick Chun

×

11

Publications

559

Citations

11

H-Index

YearCitations

Development of MK-8353, an orally administered ERK1/2 inhibitor, in patients with advanced solid tumors

Stergios J. Moschos, Ryan J. Sullivan, Wen-Jen Hwu,

JCI Insight

2018

145

Synergistic Effects of Gemcitabine and Gefitinib in the Treatment of Head and Neck Carcinoma

Patrick Chun, Felix Y. Feng, Ashley M. Scheurer,

Cancer Research

2006

78

Role of epidermal growth factor receptor degradation in gemcitabine-mediated cytotoxicity

Felix Y. Feng, Sooryanarayana Varambally, Scott A. Tomlins,

Oncogene

2006

71

Phase 1 First-in-Human Trial of AMV564, a Bivalent Bispecific (2:2) CD33/CD3 T-Cell Engager, in Patients with Relapsed/Refractory Acute Myeloid Leukemia (AML)

Peter Westervelt, Jörge E. Cortes, Jessica K. Altman,

Blood

2019

68

Effect of Epidermal Growth Factor Receptor Inhibitor Class in the Treatment of Head and Neck Cancer with Concurrent Radiochemotherapy <i>In vivo</i>

Felix Y. Feng, Carlos López, Daniel P. Normolle,

Clinical Cancer Research

2007

47

Evaluation of immune-related response criteria (irRC) in patients (pts) with advanced melanoma (MEL) treated with the anti-PD-1 monoclonal antibody MK-3475.

F. Stephen Hodi, Antoni Ribas, Adil Daud,

Journal of Clinical Oncology

2014

40

Ataxia Telangiectasia Mutated Down-regulates Phospho-Extracellular Signal-Regulated Kinase 1/2 via Activation of MKP-1 in Response to Radiation

Mukesh K. Nyati, Felix Y. Feng, Divya Maheshwari,

Cancer Research

2006

27

Randomized comparison of two doses of the anti-PD-1 monoclonal antibody MK-3475 for ipilimumab-refractory (IPI-R) and IPI-naive (IPI-N) melanoma (MEL).

Omid Hamid, Caroline Robert, Antoni Ribas,

Journal of Clinical Oncology

2014

25

Targeted <i>Cox2</i> gene deletion in intestinal epithelial cells decreases tumorigenesis in female, but not male, <i>Apc</i><sup><i>Min</i>/+</sup> mice

Durga Cherukuri, Tomo‐o Ishikawa, Patrick Chun,

Molecular Oncology

2013

23

Adjuvant Chemotherapy for Stage II Colon Cancer: The Role of Molecular Markers in Choosing Therapy.

Patrick Chun, Zev A. Wainberg

PubMed

2009

23

Page 1